[Clinical use of thymalin in the prophylaxis and treatment of infectious-inflammatory diseases of the maxillofacial region].
D000328:Adult; D000917:Antibody Formation / Q000187:drug effects; D002481:Cellulitis / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007571:Jaw Diseases / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D008297:Male; D008337:Mandibular Fractures / Q000150:complications; D008875:Middle Aged; D010019:Osteomyelitis / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D010508:Periodontal Abscess / Q000188:drug therapy* / Q000276:immunology; D010518:Periodontitis / Q000188:drug therapy*; D013949:Thymus Extracts / Q000627:therapeutic use*
D013949:Thymus Extracts
Klinicheskiĭ opyt primeneniia timalina dlia profilaktiki i lecheniia infektsionno-vospalitel'nykh zabolevaniĭ cheliustno-litsevoĭ oblasti.